Why ImmunityBio (IBRX) stock is up 7% in premarket — and what traders are watching next
ImmunityBio shares climbed 7% to $6.37 in premarket trading Tuesday, rebounding from a 10% drop before the Presidents Day market closure. Volume was light at 79,000 shares. Investors are watching for updates on Anktiva at the ASCO Genitourinary Cancers Symposium starting Feb. 26 and the company’s next earnings report expected in early March.